CA
TMDI

Claro Advisors’s Titan Medical Inc. Ordinary Shares TMDI Stock Holding History

Claro Advisors’s Portfolio TMDI Stock Details TMDI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q1 		– Sell
-1,899
Closed -$4K – 1008
2018
Q4 		$4K Buy
+1,899
New +$3.52K ﹤0.01% 836

Other funds holding TMDI

MCM
Masters Capital Management Atlanta, Georgia $3.03B AUM 57.21% 1-Year Est. Return
CH
CVI Holdings Wilmington, Delaware $116M AUM 5.68% 1-Year Est. Return
AFM
Anson Funds Management Dallas, Texas $2.29B AUM 370.24% 1-Year Est. Return
PCM
Perritt Capital Management Chicago, Illinois $59.8M AUM 26.94% 1-Year Est. Return
WVP
Worth Venture Partners Fort Lee, New Jersey $31.6M AUM 28.5% 1-Year Est. Return
Commonwealth Equity Services
Commonwealth Equity Services Waltham, Massachusetts $71.6B AUM 21.08% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
SHA
Seneca House Advisors Richmond, Virginia $252M AUM 17.04% 1-Year Est. Return
LFG
Larson Financial Group St Louis, Missouri $3.13B AUM 22.88% 1-Year Est. Return

Claro Advisors's TMDI Position: Q1 2019 in Review

Claro Advisors sold out of Titan Medical Inc. Ordinary Shares (TMDI) in Q1 2019, closing a stake of 1,899 shares — an estimated $4K sold.

Claro Advisors first reported a position in TMDI in Q4 2018 and held it in 1 quarter. The position peaked at $4K in Q4 2018. 45 funds tracked by Wall St. Rank hold TMDI as of Q1 2019.

  • Claro Advisors reported no remaining Titan Medical Inc. Ordinary Shares position as of Q1 2019 after selling out during the quarter.
  • Claro Advisors sold 1,899 Titan Medical Inc. Ordinary Shares shares in Q1 2019, an estimated $4K.
  • Claro Advisors first reported a position in Titan Medical Inc. Ordinary Shares in Q4 2018 and held it in 1 quarter.
  • Claro Advisors's Titan Medical Inc. Ordinary Shares position peaked at $4K in Q4 2018.
  • 45 funds tracked by Wall St. Rank held Titan Medical Inc. Ordinary Shares as of Q1 2019.

Based on Claro Advisors's 13F filing for Q1 2019, filed 10 May 2019.